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Abstract
Skin cancer is more prevalent than any other cancer in the United States. Non-
melanoma skin cancers are the more common forms of skin cancer that affect indi-
viduals. The development of squamous cell carcinoma, the second most common 
type of skin cancer, can be stimulated by exposure of environmental carcinogens, 
such as chemical toxicants or UVB. It is developed by three distinct stages: initia-
tion, promotion, and progression. During the initiation, the fate of DNA-damaged 
skin cells is determined by the homeostatic regulation of pro-apoptotic and anti-
apoptotic signaling pathways. The imbalance or disruption of either signaling will 
lead to the survival of initiated cells, resulting in the development of skin cancer. 
In this chapter, we will discuss signaling pathways that regulate apoptosis and the 
impact of their dysfunction during skin tumor initiation.
Keywords: apoptosis, tumor initiation, skin, carcinogen, UVB, AKT, STAT3, MAPK, 
TC-PTP
1. Introduction
Apoptosis, also called programmed cell death, is an essential cellular process that 
is required to maintain tissue homeostasis by modulating various biological func-
tions including embryonic development, cellular growth, and immunity through 
the elimination of unwanted cells. Apoptosis accompanies the distinct morphologi-
cal changes, such as membrane blebbing, cell shrinkage, chromatin condensation, 
and DNA fragmentation. These morphological changes during apoptosis were first 
observed by John Foxton R. Kerr, Andrew H. Wyllie, and Alastair Currie in 1972 
with the first description of “apoptosis” [1]. Later, the critical role of programmed 
cell death occurred during the development of the nematode Caenorhabditis elegans 
was elucidated with the finding of death-related genes in 1999 [2]. Three scientists 
– Sydney Brenner, H. Robert Horvitz, and John E. Sulston – were awarded the Nobel 
Prize in Physiology or Medicine in 2002 for their discovery of genes that regulate 
apoptosis. Since then, apoptosis has extensively been studied as a crucial biochemi-
cal mechanism for the maintenance of normal tissue function and homeostasis. 
Dysregulation of apoptosis has been involved in various types of human diseases 
including cancers and neurodegenerative diseases [3, 4].
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Cells can die prematurely by injury, infection, external assault such as chemi-
cals, or a lack of blood supply through energy-independent process of cell death, 
which is called by necrosis. Necrosis is an unplanned cellular death by external 
damage. It causes severe disorganization and rupture of subcellular structure and 
eventually leads to disruption of the cell membrane. Then, the exposure of cel-
lular components of necrotic cells into the surrounding interstitial tissue results in 
inflammation. In contrast to necrosis, apoptotic cell death is highly ordered and 
energy-dependent molecular process that can eliminate unwanted and damaged 
cells without causing inflammation [5, 6].
Apoptosis is initiated by two different pathways: the extrinsic and the intrinsic 
pathways. The extrinsic pathway is mediated by the interaction of transmembrane 
receptors known as death receptors with their ligands. Death receptors are members 
of the tumor necrosis factor (TNF) gene family and share similar cysteine-rich 
extracellular domains and homologous intracellular cytoplasmic sequence named as 
the ‘death domain’. The death domain of receptors transmits the death signal from 
the cell surface to the intracellular signaling pathways to induce apoptosis in a rapid 
and efficient manner. For example, the binding of Fas ligand with Fas receptor, 
TNFα with TNF receptor, and TNF-related apoptosis-inducing ligand (TRAIL) 
with TRAIL receptor 1, 2 results in the interaction of the death domain of receptor 
with the adaptor protein, such as Fas-associated death domain (FADD) or TNF 
receptor-associated death domain (TRADD). The adaptor protein then associ-
ates with procaspase-8 and converts it into active caspase-8 [3, 7]. Likewise, the 
intrinsic pathway, which is known as the mitochondrial pathway, is activated by a 
broad range of exogenous and endogenous stimuli including radiation, toxins, viral 
infections, and oxidative stress. It modulates mitochondrial membrane potential 
through change of the ratio of pro-apoptotic and anti-apoptotic proteins located in 
the mitochondria and releases cytochrome c from the intermembrane space into the 
cytoplasm. Cytochrome c then forms a multi-protein complex called as the ‘apopto-
some’ with apoptotic protease activating factor 1 (APAF1) and recruits inactive 
procaspase-9, which is followed by the dimerization and generation of catalytically 
active caspase-9 in an ATP-dependent manner [8, 9]. Initiation of both the extrinsic 
and intrinsic pathways can lead to the activation of executioner caspases, such as 
caspase-3, 6, or 7, resulting in the morphological changes of apoptosis [10]. These 
two apoptotic pathways are interconnected. The cleavage of pro-apoptotic protein 
Bid by caspase-8 can lead to its translocation to the mitochondria and result in 
the activation of the mitochondrial pathway [11]. Environment toxicants, such as 
ultraviolet B (UVB) radiation and chemical carcinogens, can cause severe DNA 
damage, which activates the intrinsic pathway in skin [12, 13]. UVB radiation can 
also activate the extrinsic pathway by inducing Fas receptor by p53 activation, 
promoting the association of TNF receptor 1 with TNF receptor-associated factor-2 
(TRAF-2), or inhibiting the interaction of TRAIL receptors with decoy receptors 
that serve as their negative binding partners for apoptosis (Figure 1) [14–17].
In intrinsic pathway, mitochondrial outer membrane permeability is regulated by 
pro-apoptotic or anti-apoptotic proteins of B-cell lymphoma 2 (Bcl-2) family. A total 
of 25 genes in the Bcl-2 family have been identified. The pro-apoptotic proteins of Bcl-2 
family include Bax, Bak, Bid, Bim, Bad, Noxa, Bmf, and Puma. The anti-apoptotic pro-
teins of Bcl-2 family include Bcl-2, Bcl-XL, Bcl-w, Mcl-1, and BAG. Altered expression 
of Bcl-2 family proteins has been involved in various diseases including cancer [18–21].
Skin, the largest organ of the human body, is continuously exposed to environ-
mental assaults. Exposure of skin to the chemical carcinogens or UVB radiation 
induces a mutation in critical gene or genes and forms specific carcinogen-DNA 
adducts. These adducts can be repaired by DNA repair mechanism. Otherwise, they 
need to be removed by apoptosis. Defected apoptosis by genetic abnormalities and 
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subsequent imbalanced signaling pathways can cause the survival of damaged cells 
during the tumor initiation. These damaged cells can undergo clonal expansion dur-
ing the tumor promotion and eventually develop skin cancer [22–25]. In this chap-
ter, we will review anti-apoptotic signaling pathways – AKT, STAT3, and MAPK 
– and pro-apoptotic signaling pathway – protein tyrosine phosphatases (PTPs) –, 
which are involved in the regulation of apoptosis during skin tumor initiation.
2. Anti-apoptotic signaling in skin tumor initiation
2.1 AKT signaling
AKT (protein kinase B) is the human homolog of the viral oncogene v-akt and is 
associated with protein kinases A (PKA) and C (PKC) in humans [26, 27]. The three 
known AKT isoforms are derived from distinct genes (AKT1/PKBα, AKT2/PKBβ 
and AKT3/PKBγ). The N terminus of AKT contains a pleckstrin homology domain, 
which can mediate lipid-protein and/or protein–protein interactions [28–30]. The C 
terminus of AKT contains a hydrophobic and proline-rich domain [28, 29]. AKT is 
activated by various growth factors such as platelet-derived and fibroblast growth 
factors and is involved in the regulation of cell survival signaling [31, 32]. AKT 
activation depends on its phosphorylation and four different phosphorylation sites 
on AKT (Ser-124, Thr-308, Thr-450, and Ser-473) have been identified [33]. Studies 
Figure 1. 
Mechanisms of apoptosis induced by environmental carcinogens in skin. Apoptosis is initiated by two major 
pathways: The extrinsic and the intrinsic pathways. The extrinsic pathway is mediated by death receptors, 
such as Fas receptor. Upon binding to Fas ligand, Fas receptor interacts with FADD and recruits procaspase-8, 
which is followed by activation of caspase-8. The intrinsic pathway causes DNA damage and modulates 
mitochondrial membrane potential. Then, cytochrome c is released from the mitochondria into the cytoplasm. 
The formation of apoptosome with cytochrome c and APAF1 recruits and activates caspase-9. Activation of 
either caspase-8 or caspase-9 leads to the activation of executioner caspases including caspase-3, resulting in 
the morphological changes of apoptosis. These two pathways are also interconnected. The cleavage of bid by 
caspase-8 leads to its translocation to the mitochondria and activates the mitochondrial pathway. Environment 
toxicants, such as UVB radiation and chemical carcinogens, cause severe DNA damage and activate the 
intrinsic pathway in skin. UVB radiation activates the extrinsic pathway by activating death receptors and 
enhancing the association of death receptors with their ligands.
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showed that extracellular stimuli induce the phosphorylation of AKT at Thr-308 and 
Ser-473 residues while the phosphorylation of AKT at Ser-124 and Thr-450 residues 
appears to be basally maintained [33]. Mutagenesis studies have revealed that the 
phosphorylation of AKT at Thr-308 and Ser-473 is required for its activation [34].
It has been shown that AKT signaling inactivates several pro-apoptotic fac-
tors including BAD, procaspase-9 and Forkhead transcription factors [35, 36]. 
In contrast, AKT activates various transcription factors that are involved in the 
upregulation of anti-apoptotic genes, such as cyclic-AMP response element-binding 
protein (CREB). It also activates IκB kinase (IKK) to phosphorylate IκB (inhibitor 
of NF-κB), leading to its proteasomal degradation and NF-κB nuclear localization. 
In addition, AKT reduces the protein levels of p53 by promoting its degradation 
through MDM2 phosphorylation, which can contribute to centrosome hyper-
amplification and chromosome instability in cancer [37, 38]. Furthermore, AKT is 
involved in the regulation of subcellular localization of proteins. AKT can regulate 
the localization of various proteins and thereby their activity by phosphorylating 
specific binding sites for 14–3-3 proteins, which play a crucial role in the modula-
tion of cellular location and degradation of proteins [39, 40].
Studies have shown that AKT is activated by environmental toxicants includ-
ing UVB irradiation which protects keratinocytes against environmental attacks, 
implying its anti-apoptotic role in skin tumor initiation. It has been shown that 
UV radiation induces phosphorylation of AKT at Ser-473 and Thr-308 residues 
in mouse epidermal cell JB6 Cl41 in a time-dependent manner. These results were 
further confirmed by the observation that overexpression of AKT mutant, AKT-
T308A/S473A, attenuated phosphorylation of AKT at Ser-473 and Thr-308 upon 
UVB irradiation [41]. The reactive oxygen species (ROS) generated by UV radiation 
acts as a mediator in UV-induced phosphorylation of AKT. It has been observed 
that pre-treatment of cells with either an antioxidant, N-acetyl-L-cysteine (NAC) 
or a specific antioxidant enzyme (catalase) inhibits phosphorylation of AKT in 
these cells, suggesting the link of ROS in UV radiation-induced activation of AKT 
[41]. Specific phosphorylation of Bad, a pro-apoptotic member of the Bcl-2 family, 
by AKT delayed the early activated apoptotic pathways in UVB-exposed human 
keratinocytes. AKT-mediated phosphorylation of Bad at serine 136 residue pro-
moted its translocation from the mitochondria to the cytoplasm and subsequent 
cytoplasmic sequestration by 14–3-3ζ, resulting in the reduction of UVB-induced 
apoptosis in keratinocytes [42]. In addition to its anti-apoptotic function, studies 
using transgenic mice have shown that AKT can contribute to the development of 
skin cancer formation induced by environmental exposure through the regulation 
of epidermal proliferation. It has been shown that mice lacking Akt1−/−;Akt2−/− or 
Akt1−/−;Akt3+/− exhibit a hypoplastic epidermis due to decreased proliferation of 
keratinocytes while overexpression of wild type AKT1 (wtAkt) or constitutively 
active AKT (myrAkt) in the basal layer of mouse epidermis displays alterations 
in epidermal proliferation and differentiation [43–45]. Overexpression of either 
wtAKT or myrAKT in mouse epidermis displayed enhanced sensitivity to two stage 
skin carcinogenesis by promoting cell proliferation [45]. These studies suggest that 
AKT plays a critical role in the regulation of apoptosis and proliferation during skin 
carcinogenesis. Further detailed studies using transgenic mouse models will be 
helpful to elucidate the underlying molecular mechanisms and function of AKT in 
the initiation of skin carcinogenesis.
2.2 STAT3 signaling
Signal transducer and activator of transcription 3 (STAT3) is one of the family 
members of seven [STAT1 (α and β splice isoforms), STAT2 and STAT3 (α and β 
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isoforms), STAT4, STAT5a, STAT5b, and STAT6)] latent cytoplasmic transcription 
factors which are encoded by seven individual genes [46]. STATs are phosphory-
lated at their specific tyrosine residue and activated by a wide variety of stimuli 
including growth factors and cytokines, which act through intrinsic receptor 
tyrosine kinases [47]. Tyrosine phosphorylation of STAT induces its dimerization 
via reciprocal interaction of phospho-tyrosine with Src homology domain 2 (SH2) 
between two STAT molecules. The phosphorylated STATs then translocate to the 
nucleus and bind to the consensus promoter sequences of downstream target genes, 
resulting in the activation of their transcription [48].
Different tyrosine kinases, such as RTKs (receptor tyrosine kinases) and 
non-RTKs including JAKs (Janus kinases), can phosphorylate STAT proteins. 
STAT tyrosine phosphorylation is transient, which lasts from 30 minutes to 
several hours in normal cells. However, studies have shown that STATs (specifi-
cally STAT3) are persistently tyrosine phosphorylated either as a consequence of 
deregulation of positive regulators of STAT activation such as tyrosine kinases or 
deactivation of negative regulators of STAT phosphorylation, such as phospha-
tases, suppressor of cytokine signaling, or protein inhibitor of activated STATs, in 
numerous cancer-derived cell lines or in primary tumors [49].
Studies have revealed that STAT3 is associated with cell survival and oncogenic 
transformation among the seven members of STATs. It has shown that targeted 
inhibition of STAT3 activation by antisense, small interfering RNA, dominant-
negative STAT3 constructs, and/or blockade of tyrosine kinases has been associ-
ated with growth arrest and induction of apoptosis in cancer cell lines [49]. 
Furthermore, overexpression of constitutively activated STAT3 into immortalized 
cell lines led to oncogenic transformation, indicating a potential role of STAT3 in 
carcinogenesis [50, 51].
The generation of epidermal-specific STAT3-dificient and STAT3-overexpressing 
transgenic mice led to the main discovery of functional role of STAT3 in the initia-
tion stage of skin carcinogenesis [52, 53]. Epidermal-specific deficiency of STAT3 
in mouse (K5Cre.Stat3fl/fl) significantly increased the sensitivity to apoptosis after 
7,12-dimethylbenz[a]anthracene (DMBA) treatment both in vitro keratinocytes 
and in vivo epidermis compared with non-transgenic controls, as determined by 
increased caspase-3-positive cells. In particular, the significant increase in the num-
ber of keratinocyte stem cells (KSCs) undergoing apoptosis in the bulge region of 
hair follicles was observed in STAT3-deficient mice compared with non-transgenic 
littermates, indicating that STAT3 may be critical for maintaining the survival 
of KSCs during skin tumor initiation mediated by DMBA [54]. Similar with this 
observation, forced expression of a constitutively active form of STAT3 in mouse 
epidermis (K5.Stat3C) showed increased cell survival following DMBA exposure 
[55]. Further studies showed that STAT3 plays a critical role in the protection of 
damaged keratinocytes after UVB exposure. The epidermis of STAT3-deficient 
mice was highly sensitive to UVB-induced apoptosis compared with the epidermis 
of control mice, whereas the epidermis of K5.Stat3C mice was more resistant to 
UVB-induced apoptosis compared with the epidermis of control mice. UVB induces 
DNA damage and causes mutations in runs of tandemly located pyrimidine residues 
of DNA, resulting in the generation of cyclobutane pyrimidine dimers (CPDs) and 
pyrimidine (6–4) pyrimidone photoproducts (6–4 PPs). The number of either 6–4 
PP- or CPD-positive cells was greater in epidermis of K5.Stat3C mice compared 
with epidermis from STAT3-deficient mice after UVB exposure [56]. Additionally, 
generation of inducible STAT3-deficient mice (K5.Cre-ERT2 x Stat3fl/fl) clearly 
demonstrated that STAT3 has a critical role in the protection of keratinocytes during 
tumor initiation. Inducible deletion of STAT3 in mouse epidermis significantly 
increased apoptosis after DMBA treatment. Inducible STAT3 deletion in epidermis 
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before initiation with DMBA showed a significant delay in tumor development and a 
significantly reduced number of tumors compared with control groups in two-stage 
skin carcinogenesis [57].
Expression of Ha-ras homolog (v-Ha-ras) into cultured primary keratinocytes in 
vitro has been utilized to generate initiated keratinocytes. Studies showed that the 
introduction of a STAT3 decoy molecule into the v-Ha-ras–initiated keratinocytes 
increases apoptosis with a concomitant decrease in Bcl-xL expression levels. In 
general, inhibition of STAT3 activation can lead to increase apoptosis or growth 
arrest in cancer-derived cell lines containing high levels of phosphorylated STAT3. 
However, STAT3 inhibition was not relatively affected in cell lines containing low 
or no levels of detectable tyrosine phosphorylated STAT3. Therefore, how STAT3 
can protect keratinocytes against DMBA-induced apoptosis remains to be unclear, 
because DMBA does not induce tyrosine phosphorylation of STAT3 in keratino-
cytes, nor is it likely that v-Ha-ras–containing keratinocytes contain abundant 
levels of phosphorylated STAT3 [58]. One possible explanation is that the low levels 
of phosphorylated STAT3 present in these keratinocytes are sufficient to drive tran-
scription of anti-apoptotic genes such as Bcl-xL. Alternatively, it is also possible that 
non-phosphorylated STAT3 may play a role as a transcription factor as previously 
demonstrated for STAT1 [59]. There are a few notable examples where relatively low 
levels of phosphorylated STAT3 are sufficient to mediate protection from growth 
arrest or apoptosis [60, 61]. Therefore, determination of the relative levels of phos-
phorylated STAT3 required to impart a phenotype is likely to be cell-type specific 
and remains an important objective.
It suggests that KSCs, which are located mostly within the bulge region of the 
hair follicle, are the major target cells for two-stage carcinogenesis [62]. The label-
retaining cells (LRCs) retain the label for a sustained period of time following con-
tinuous administration of nucleotide analogs such as bromodeoxyuridine (BrdU) 
or [3H] thymidine, indicating a very slow cycling frequency. Studies showed that 
hair follicle KSCs are identified within the LRCs [63, 64]. It has been observed that 
the STAT3-deficient keratinocytes undergoing apoptosis following DMBA exposure 
were located primarily within the bulge region of the hair follicle in an area adjacent 
to the LRC population. It indicates that the DMBA-sensitive cells may be KSCs, 
given their proximity to the LRCs. However, given the lack of overlap between the 
LRCs and the apoptotic cells, the cell type most sensitive to DMBA-induced apop-
tosis remains to be identified. Studies using inducible bulge-region KSC-specific 
STAT3-deficient mice (K15.CrePR1 x Stat3fl/fl mice) have provided further evidence 
that STAT3 is required for survival of bulge-region KSCs during the initiation 
stage of skin carcinogenesis [65]. In these studies, the number of apoptotic KSCs 
in the bulge-region was significantly increased in K15.CrePR1 x Stat3fl/fl mice by 
inducible deletion of STAT3 prior to tumor initiation with DMBA compared with 
control littermates. In addition, the frequency of Ha-ras codon 61 A182 → T muta-
tions was decreased in K15.CrePR1 x Stat3fl/fl mice compared to control mice [65]. 
Furthermore, the number of skin tumors that developed in a two-stage skin carci-
nogenesis protocol was dramatically reduced by targeted deletion of STAT3 in bulge 
region KSCs at the time of initiation [65]. Overall, these studies provide molecular 
basis of STAT3 involvement in the initiation of skin carcinogenesis.
2.3 MAPK signaling
Mitogen-activated protein kinases (MAPKs) are essential signaling components 
that are vital in converting extracellular stimuli into intracellular responses through 
transcriptional regulation of various regulatory genes. MAPK signaling is activated 
by sequential protein kinase cascades including three enzymes: a MAPK kinase 
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kinase (MAPKKK), a MAPK kinase (MAPKK) and a MAPK [66]. MAPK signal-
ing pathways are involved in the regulation of a wide variety of cellular processes 
including cell proliferation, differentiation, development, stress responses and 
apoptosis. Therefore, MAPK signaling is considered as one of potential therapeutic 
targets for many signaling-related diseases including cancer and diabetes. Three 
structurally related but biochemically and functionally distinct MAPKs are identi-
fied and named as extracellular signal-regulated kinases (ERKs), c-Jun N terminal 
kinases (JNKs) and p38 MAPKs [67–70].
ERK was the first MAPK identified and contains two isoforms: ERK1 and ERK2. 
ERK plays a critical role in the signaling of a variety of extracellular stimuli, such 
as growth factors and phorbol esters. ERK signaling is involved in the regulation 
of cell cycle progression and cell proliferation as one of major checkpoint signal-
ing pathways for cellular mitogenesis [66, 71]. JNK was initially identified as a 
regulator of transcription factor c-Jun and consisted of three isoforms: JNK1, JNK2, 
and JNK3. JNK is also known as a stress-activated protein kinase (SAPK) as it is 
stimulated by various intra- or extracellular stresses. JNK signaling is involved in 
many cellular processes including immune response, neuronal activity, and insulin 
signaling [70, 72]. Studies have also shown that JNK signaling is critical in the pro-
motion of apoptosis in response to a variety of harmful external stimuli through p53 
activation [73, 74]. p38 MAPK contains four isoforms: p38α, p38β, p38δ, and p38γ. 
p38 MAPK is another SAPK and is activated by stress related stimuli. Similar with 
JNK, p38 MAPK is also involved in many cellular processes including apoptosis, 
inflammation, migration, differentiation, and cell cycle checkpoints [68, 75, 76].
In skin keratinocytes, both ERK and JNK are activated by UVB irradiation and 
protect cells against UVB-induced apoptosis [77, 78]. JNK is significantly activated 
by UVB exposure and pretreatment of antioxidant N-acetylcysteine reduced its 
activation, implying UVB-induced oxidative stress plays an important role in the 
activation of JNK [77]. Furthermore, UVB-mediated generation of reactive oxy-
gen species significantly increased the activation of both JNK and ERK in human 
keratinocytes. Activated JNK and ERK then induced the upregulation of Bcl-2 
and adenovirus E1B 19-kDa interacting protein 3 (BNIP3) expression, which is 
known to protect keratinocytes from UVB-induced apoptosis through autophagy. 
Pretreatment with the antioxidant N-acetylcysteine, the JNK inhibitor SP600125, 
or the ERK inhibitor U0126 significantly reduced the expression of BNIP3 upon 
UVB exposure and decreased cell survival by inducing apoptosis [78]. p38 MAPK 
is also activated by UVB irradiation [79]. However, in contrast to JNK and ERK, 
p38 MAPK promotes epidermal apoptosis following UVB exposure in mouse skin. 
The epidermis of transgenic mice that express a dominant negative p38α MAPK 
(p38DN) showed a significant reduction in UVB-induced apoptosis compared with 
the epidermis of control mice. The p38DN mice also showed a significant reduction 
of tumor number and growth compared to wild-type mice in UVB skin carcinogen-
esis assay [80]. Overall, it implies that JNK and ERK may protect damaged keratino-
cytes by reducing apoptosis during the initiation of skin carcinogenesis induced by 
environmental carcinogens, while p38 MAPK may contribute to remove damaged 
keratinocytes by promoting apoptosis in response to environmental exposure.
3. Pro-apoptotic signaling in skin tumor initiation
3.1 PTPs in skin
PTPs negatively regulate the rate and duration of phosphotyrosine signaling as 
an endogenous negative feedback mechanism of protein tyrosine kinases (PTKs) 
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[81–84]. PTPs were first identified in the late 1980s by Nicholas Tonks and col-
leagues 10 years after the discovery of PTKs [85]. Since then, 107 PTPs have been 
identified in the human genome by using the conserved catalytic domain of PTPs to 
search the human genome database [86, 87].
It has been shown that PTP expression is induced during proliferation and matu-
ration of keratinocytes, however their expression levels remain unchanged within 
skin epidermis [88]. In contrast, microarray analysis has shown that expression 
of PTPs, such as PTPκ and PTPλ decreases in human melanoma tissue compared 
with its normal counterpart [89, 90]. Studies showed that acute ultraviolet (UV) 
exposure leads to the ligand-independent activation of PTKs [91, 92]. This result 
indicates that UV radiation may reduce PTP activation. With this regard, biochemi-
cal analysis showed that reactive oxygen species (such as H2O2) produced by UV 
irradiation caused the inactivation of PTPs through the oxidization of the cysteine 
residue located within the conserved active-site of the PTP catalytic domain 
[93–95]. Furthermore, studies performed by different groups have revealed that 
acute UV exposure can trigger PTP inactivation in keratinocytes [96, 97].
In contrast to previous findings of PTP inactivation observed in skin, studies 
revealed that three PTPs, T-cell protein tyrosine phosphatase (TC-PTP), Src homol-
ogy region 2 domain-containing phosphatase 1 (SHP1), and SHP2, can cooperate 
in the dephosphorylation of STAT3 in response to UVB irradiation [98]. STAT3 
was rapidly dephosphorylated in keratinocytes after UVB irradiation. Knockdown 
of TC-PTP, SHP1, or SHP2 using RNAi in keratinocytes before UVB exposure 
partially recovered the level of phosphorylated STAT3 at Tyr 705 (PY-STAT3) 
compared to control keratinocytes, indicating that these PTPs are responsible for 
the rapid STAT3 dephosphorylation observed following UVB exposure. Further 
studies revealed that knockdown of all three phosphatases, using RNAi, prevented 
the rapid dephosphorylation of STAT3 following UVB irradiation [98]. This result 
suggests that exposure to UVB triggers PTP activation, which attenuates STAT3 
signaling by dephosphorylating PY-STAT3. It implies that this activation of PTP can 
contribute to increase UVB-induced apoptosis during tumor initiation by deactivat-
ing STAT3, one of major survival factors in skin.
3.2 TC-PTP/PTPN2 signaling
Among three PTPs involved in STAT3 dephosphorylation of keratinocytes 
after UVB exposure, further investigation revealed that TC-PTP is the major PTP 
involved in the regulation of STAT3 signaling in keratinocytes following UVB 
exposure. TC-PTP activity was steadily increased after treatment of low-dose of 
UVB (10 mJ/cm2), which can contribute to STAT3 dephosphorylation in mouse 
keratinocytes. Knockdown of TC-PTP in mouse 3PC keratinocytes significantly 
suppressed UVB-induced apoptosis with decreased caspase-3 activity compared to 
control keratinocytes [99].
TC-PTP was one of the first members of the PTP gene family to be identified. It 
is encoded by protein tyrosine phosphatase non-receptor type 2 (PTPN2). As one of 
17 intracellular, non-receptor PTPs, TC-PTP is broadly expressed in most embryonic 
and adult tissues, but it is highly expressed in hematopoietic tissues [100, 101]. Two 
different forms of TC-PTP are generated by alternative splicing at the 3′ end of the 
gene: TC45 (TC-PTPa) and TC48 (TC-PTPb). TC45 (45 kDa) is the major form of 
TC-PTP in most species, including humans and mice. TC45 is mainly localized in the 
nucleus with a bipartite nuclear localization signal (NLS) in its C-terminal domain, 
while TC48 (48 kDa) is localized to the endoplasmic reticulum with its hydrophobic 
C terminus. Studies have shown that almost all TC-PTP mRNA encodes TC45 in 
mouse tissue and TC48 mRNA is not detectable by Northern blot analysis [102–104].
9
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Recent generation of epidermal-specific TC-PTP knockout (K14Cre.Ptpn2fl/fl;  
TC-PTP KO) transgenic mice as in vivo models has provided an evidence that 
TC-PTP plays a crucial role in the promotion of epidermal apoptosis induced 
by environmental assaults [105, 106]. TC-PTP deficiency in mouse epidermis 
led to a desensitization to tumor initiator DMBA-induced apoptosis both in vivo 
epidermis and in vitro keratinocytes. The number of apoptotic cells, detected by 
active caspase-3 staining, within the epidermis of control (TC-PTP WT) mice 
was significantly increased compared to TC-PTP KO mouse epidermis following 
DMBA treatment. Profound morphological changes induced by apoptosis, such 
as cell ballooning and bleb formation, were found in TC-PTP WT keratinocytes 
compared to TC-PTP KO keratinocytes. Similarly, annexin V-positive cells and 
caspase-3 activity were significantly increased in TC-PTP WT keratinocytes com-
pared to TC-PTP KO keratinocytes. Inhibition of STAT3 or AKT in TC-PTP KO 
keratinocytes significantly reversed the effects of TC-PTP deficiency on apoptosis 
by increasing cellular sensitivity and caspase-3 activity following DMBA treatment 
compared to control keratinocytes [105]. Further studies also showed that TC-PTP 
KO cells showed increased survival against UVB-induced apoptosis compared to 
control, which was concomitant with a UVB-mediated increase in the level of Flk-1 
(fetal liver kinase-1, known as VEGFR2) phosphorylation. Immunoprecipitation 
of the TC-PTP substrate-trapping mutant TCPTP-D182A showed that TC-PTP 
directly interacts with Flk-1 to dephosphorylate it and their interaction was stimu-
lated by UVB irradiation. Following UVB-mediated Flk-1 phosphorylation in the 
absence of TC-PTP, the level of phosphorylated JNK was significantly increased in 
TC-PTP KO cells compared to TC-PTP WT cells after UVB irradiation. Inhibition 
of Flk-1 or JNK by their specific inhibitors in TC-PTP KO cells reversed this 
effect and significantly increased UVB-induced apoptosis compared to untreated 
TC-PTP KO cells [106].
The nuclear form of TC-PTP (TC45) contains bipartite nuclear localization sig-
nals (NLSI and NLSII) in its C-terminus, and TC45 had been known to be primarily 
localized in the cell nucleus due to its NLS [103]. However, recent studies have 
showed that TC45 is mainly localized to the cytoplasm of keratinocytes. TC45 is 
translocated to the nucleus following UVB irradiation [98]. TC45 nuclear transloca-
tion increased its activity in the nucleus and resulted in an increase of UVB-induced 
apoptosis which corresponded to a decrease in nuclear phosphorylated STAT3. UVB 
irradiation activated AKT to trigger nuclear translocation of TC45 and the adaptor 
protein 14–3-3σ. Furthermore, site-directed mutagenesis of putative 14–3-3σ bind-
ing sites within TC45 revealed that a substitution at threonine 179 (TC45/T179A) 
effectively blocked UVB-induced nuclear translocation of exogenous TC45 due to 
the disruption of the direct binding between TC45 and 14–3-3σ. Overexpression 
of TC45/T179A in keratinocytes resulted in decreased UVB-induced apoptosis, 
indicating that TC45 nuclear translocation is an important step to induce apoptosis 
against UVB-mediated damage [107].
Recent generation of epidermal-specific TC-PTP-overexpressing (K5HA.Ptpn2) 
mouse model further demonstrated that TC-PTP has a critical role for the induc-
tion of epidermal apoptosis against chemical carcinogen [108]. Overexpression of 
TC-PTP increased epidermal sensitivity to DMBA-induced apoptosis through the 
synergistic regulation of STAT1, STAT3, STAT5, and PI3K/AKT signaling. Inhibition 
of STAT1, STAT3, STAT5, or AKT reversed the effects of TC-PTP overexpression on 
epidermal apoptosis after DMBA treatment [108].
Overall, these studies suggest that TC-PTP plays a protective role against 
environmental carcinogens by increasing epidermal apoptosis through the 
regulation of AKT, STAT including STAT3, and Flk-1/JNK signaling pathways 
(Figure 2).
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4. Conclusion
Apoptosis is a critical cellular process to protect keratinocytes during skin 
tumor initiation. Environmental assaults induce a mutation in a critical gene or 
genes. Apoptosis can remove DNA-damaged keratinocytes that are not repaired 
via DNA damage repair mechanism. Survival of damaged keratinocytes by 
increased anti-apoptotic signaling pathways or decreased pro-apoptotic signaling 
pathways will lead to clonal expansion of them during skin tumor promotion, 
which is followed by the formation of papilloma and then squamous cell car-
cinoma. In this chapter, we outline the functional significance of three – AKT, 
STAT3, and MAPK – anti-apoptotic signaling pathways and TC-PTP as a pro-
apoptotic signaling pathway in the regulation of apoptosis during skin tumor 
initiation. Besides them, different signaling pathways are involved in modulating 
apoptosis during skin tumor initiation depending on the types of environmental 
assaults and interconnected with signaling pathways we mentioned in this chap-
ter. Further understanding of signaling mechanisms and their function in envi-
ronmentally induced epidermal apoptosis during tumor initiation will contribute 
to develop novel therapeutic interventions for the prevention and treatment of 
skin cancer.
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Figure 2. 
Anti-apoptotic and pro-apoptotic signaling pathways in the regulation of skin tumor initiation induced by 
environmental carcinogens. AKT, STAT3, ERK, and JNK signaling pathways inhibit epidermal apoptosis 
in response to environmental carcinogens, such as UVB and chemical carcinogens/toxins, which can lead 
to survival of DNA damaged cells during tumor initiation. These initiated cells are clonally expanded 
by accelerated proliferation during tumor promotion and form benign skin tumor called by ‘papilloma’. 
On the other hand, TC-PTP signaling pathway is initially activated against environmental exposure. 
TC-PTP signaling attenuates AKT, STAT3, and JNK signaling pathway through either direct or indirect 
dephosphorylation and increases epidermal apoptosis as one of initial protective mechanisms in skin. p38 
MAPK signaling pathway is also activated and may contribute to increase epidermal apoptosis following 
environmental exposure.
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Appendices and nomenclature
6-4PP pyrimidine (6–4) pyrimidone photoproduct
AKT a serine/threonine specific protein kinase, known as protein 
kinase B (PKB)
APAF1 apoptotic protease activating factor 1
Bcl-2 B-cell lymphoma 2
BNIP3 Bcl-2 and adenovirus E1B 19-kDa interacting protein 3
Caspase cysteine-aspartic protease, cysteine aspartase or cysteine-depen-
dent aspartate-directed protease
CREB cyclic-AMP response element-binding protein
CPD cyclobutane pyrimidine dimer
DMBA 7,12-dimethylbenz[a]anthracene
ERK extracellular signal-regulated kinase
FADD Fas-associated death domain
Flk-1 fetal liver kinase-1, known as VEGFR2
JAK Janus kinase




KSC keratinocyte stem cell
LRC label-retaining cell
MAPK mitogen-activated protein kinase
NLS nuclear localization signal
p38DN dominant negative p38α MAPK
PTP protein tyrosine phosphatase
PTK protein tyrosine kinase
PTPN2 protein tyrosine phosphatase non-receptor type 2
PY-STAT3 phosphorylated STAT3 on the tyrosine residue
RNAi RNA interference
RTK receptor tyrosine kinase
SAPK  stress-activated protein kinase
SHP-1 Src homology region 2 domain-containing phosphatase-1
SHP-2 Src homology region 2 domain-containing phosphatase-2
STAT3 signal transducer and activator of transcription 3
TC-PTP T-cell protein tyrosine phosphatase
TRADD TNF receptor-associated death domain
TRAF-2 TNF receptor-associated factor-2
TRAIL TNF-related apoptosis-inducing ligand
TNF tumor necrosis factor
UVB ultraviolet B
WT wild type
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